<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
  • ABOUT US  /  OUR COMPANY

Our Company

Headquartered in California, US, Crown Bioscience is a global contract research organization (CRO) providing discovery, preclinical and translational platforms and services to advance oncology, immuno-oncology, and immune-mediated inflammatory diseases.

We are known for our high-quality and expansive in vivo, in vitro, and ex vivo preclinical models, and partner with our clients to quantify the efficacy and pharmacological profile of their drug candidate(s) before they move into the clinic. We aim to deliver superior drug candidates to ensure that patients get the right treatment at the right time.

  1. 2006

    Crown Bioscience Inc. founded

  2. 2007
    Oncology Platform Established
  3. 2008
    Biologics platform established

    New R&D Centre founded in Taicang, China

  4. 2009

    Crown Bioscience US R&D site founded

  5. 2013

    Acquisition of PRECOS Ltd. (Now Crown Bioscience UK)

  6. 2013
    Bioluminescence Imaging platform established
  7. 2014

    Crown BioScience Taiwan founded

  8. 2015

    Expansion of Western PDX Models

  9. 2015

    Expansion of Western PDX Models

  10. 2017

    Acquisition of Molecular Response (Now Crown Bioscience San Diego, US)

  11. 2017
    Inflammation Platform Established
  12. 2017

    Expansion of UK & US Oncology Facilities

  13. 2018

    Expansion of Bioinformatics Facilities, Suzhou, China

  14. 2018

    Acquisition by JSR Corporation

  15. 2019
    Organoid Platform Established
  16. 2020

    Expansion of China Oncology Facilities in Zhongshan

  17. 2020

    Crown Bioscience Netherlands organoid center founded

  18. 2021

    Acquisition of OcellO B.V. Expansion of in vitro capability

 

Our Brand

HubSpot Video


About JSR Life Sciences

JSR Life SciencesCrown Bioscience is a division of JSR Life Sciences, part of the multinational JSR Corporation.

JSR Life Sciences provides specialized technology, products, materials, and services to biopharmaceutical companies and life science researchers.

Through the service offerings of our affiliates, including Crown Bioscience, JSR has created a framework that provides a fully integrated drug development process, from discovery through commercial production, that accelerates development timelines and can increase clinical success rates.

Contract research organization Crown Bioscience offers preclinical drug discovery and development services including translational platforms to advance oncology, immuno-oncology and inflammatory disorders.

Learn More

MBL implements biomarker discovery for companion diagnostics, and the development and manufacturing of in vitro diagnostics (IVDS) for immunological and genetic testing.

Learn More


Selexis SA is the global leader in cell line development with best-in-class modular technology and a highly specialized platform that accelerates biologics discovery and production.

Learn More


KBI Biopharma provides deep analytical services, process development, and GMP manufacturing for clinical trials and commercialization of biopharmaceuticals.

Learn More